皮膚経由のミトラバルブ整形術後の重要なミトラバルブ吐の長期的なアウトカム
Mi-Jeong Kim1, Jae-Kwan Song, Jong-Min Song
1Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Poongnap-dong Songpa-ku, Seoul 138-736 South Korea.
Circulation
|December 13, 2006
まとめ
皮膚経由ミトラバルブ整形術 (PMV) の後の有意なミトラバルブ吐 (MR) は,その原因に基づいてさまざまなアウトカムがあります. 修理現場から発生したコンシューラ MRは,非コンシューラ MRよりも長期的なイベントフリー生存率が優れている.
科学分野:
- 心臓病学 心臓病学
- 介入性心臓病学 介入性心臓病学
- エコーカルディオグラフィー エコーカルディオグラフィー
背景:
- 軽度のコミッショラル・ミトラル・リグルジテーション (MR) は,パーキュタヌス・ミトラル・バルブプラスティ (PMV) の後のレステノシスフリー生存率の改善と相関する.
- これは,PMV.の後の基礎メカニズムに基づいて,有意なMRの異なる臨床経路を示唆しています.
研究 の 目的:
- PMV後の有意なMRの長期的な予後要因を分析する.
- PMV.の後に有意なMRのメカニズムに基づいて臨床的アウトカムを区別する.
主な方法:
- イヌーエ風船技法 (1995-2000年) でPMVを受けた380人の患者のエコーカルディオグラフィと臨床フォローアップデータの分析.
- 重要なMRをコミッショル型と非コミッショル型に分類し,さらに非コミッショル型MRをサブ分類する.
- ミトラ弁置換の独立した予測要因を特定するための多変量分析.
主要な成果:
- 患者の12.4%で有意なMRが発症し,8年生存率はグループ間で比較可能であった (96%対98%).
- 委員のMR (57%) は,非委員のMR (43%) よりも頻繁でした.
- 8年イベントフリー生存率は,有意なMR (47%) と無意味なMR (83%) の患者で,有意なMR (63%) と非有意なMR (29%) の患者で,有意なMR (47%) と無意味なMR (83%) の患者で,有意なMR (63%) と非有意なMR (29%) の患者で,有意なMR (63%) と非有意なMR (29%) の患者で,有意なMR (83%) と非有意なMR (29%) の患者で,有意なMR (83%) と非有意なMR (29%) の患者で,有意なMR (63%) と非有意なMR (29%) で,有意なMR (63%) と非有意なMR (29%) で,有意なMR (83%) と非有意なMR (29%) で,有意なMR (83%) で,有意なMR (63%) で,有意なMR (83%) で,有意なMR (8%) で,有意なMR (8%) で,有意なMR (8%) で,有意なMR) であった.
- ミトラ弁置換を予測する要因には,心房細動,PMV後の平均ミトラグラデント,およびMRメカニズム (非診察) が含まれる.
結論:
- PMV後の有意なMRの臨床結果は,MRメカニズムと即時の血液動力学的改善によって影響を受けます.
- PMVの直後の心拍は,血液動力学的状態を効果的に評価し,結果を予測することができます.
関連する概念動画
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...


